Larvol Delta - ANDECAHO-A-Study-of-Andecaliximab-in-People-With-Spinal-Cord-Injury-at-Risk-for-Bone-Growth-Outside-of-the-Normal-Skeleton

andecaliximab (GS-5745) - Gilead

http://clinicaltrials.gov/ct2/show/NCT07024407

Jun 17, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next